The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Rothera Mark since 2013.
The trader's CIK number is 1550424.
At the time of the last reporting, Rothera Mark was the Chief Commercial Officer of Ptc Therapeutics, Inc.. (stock ticker symbol PTCT).
Also see all insider trading activities at Ptc Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | PTCT | 0 | $0 | 0 | $0 | 11,216 | $121,693 |
| 2016 | PTCT | 2,000 | $12,460 | 0 | $0 | 9,216 | $99,992 |
| 2015 | PTCT | 0 | $0 | 61,000 | $4,082,967 | 61,216 | $664,193 |
| 2014 | PTCT | 0 | $0 | 24,000 | $1,006,435 | 8,000 | $86,800 |
| 2013 | PTCT | 25,000 | $375,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-05-24 | PTCT | Option Ex | 2,000 | 10.85 | 21,700 |
| 2017-03-15 | PTCT | Option Ex | 2,966 | 10.85 | 32,181 |
| 2017-02-16 | PTCT | Option Ex | 3,125 | 10.85 | 33,906 |
| 2017-01-17 | PTCT | Option Ex | 3,125 | 10.85 | 33,906 |
| 2016-11-14 | PTCT | Option Ex | 1,941 | 10.85 | 21,059 |
| 2016-10-10 | PTCT | Option Ex | 1,950 | 10.85 | 21,157 |
| 2016-09-26 | PTCT | Option Ex | 2,200 | 10.85 | 23,870 |
| 2016-03-03 | PTCT | Buy | 2,000 | 6.23 | 12,460 |
| 2016-01-15 | PTCT | Option Ex | 3,125 | 10.85 | 33,906 |
| 2015-07-21 | PTCT | Option Ex | 9,216 | 10.85 | 99,993 |
| 2015-03-17 | PTCT | Option Ex | 10,700 | 10.85 | 116,095 |
| 2015-03-17 | PTCT | Sale | 10,700 | 76.64 | 820,048 |
| 2015-03-13 | PTCT | Option Ex | 300 | 10.85 | 3,255 |
| 2015-03-13 | PTCT | Sale | 300 | 76.36 | 22,908 |
| 2015-02-23 | PTCT | Option Ex | 20,000 | 10.85 | 217,000 |
| 2015-02-24 | PTCT | Option Ex | 1,000 | 10.85 | 10,850 |
| 2015-02-23 | PTCT | Sale | 23,000 | 64.73 | 1,488,721 |
| 2015-02-25 | PTCT | Option Ex | 11,000 | 10.85 | 119,350 |
| 2015-02-24 | PTCT | Sale | 1,000 | 67.70 | 67,700 |
| 2015-02-25 | PTCT | Sale | 11,000 | 73.49 | 808,390 |
| 2015-01-20 | PTCT | Sale | 3,000 | 60.02 | 180,060 |
| 2015-01-16 | PTCT | Option Ex | 2,300 | 10.85 | 24,955 |
| 2015-01-16 | PTCT | Sale | 2,300 | 58.67 | 134,941 |
| 2015-01-14 | PTCT | Sale | 1,200 | 58.62 | 70,344 |
| 2015-01-13 | PTCT | Sale | 8,500 | 57.63 | 489,855 |
| 2015-01-14 | PTCT | Option Ex | 1,200 | 10.85 | 13,020 |
| 2015-01-13 | PTCT | Option Ex | 5,500 | 10.85 | 59,675 |
| 2014-09-25 | PTCT | Sale | 10,100 | 44.53 | 449,803 |
| 2014-09-26 | PTCT | Sale | 3,000 | 46.90 | 140,700 |
| 2014-09-24 | PTCT | Option Ex | 900 | 10.85 | 9,765 |
| 2014-09-25 | PTCT | Option Ex | 7,100 | 10.85 | 77,035 |
| 2014-09-24 | PTCT | Sale | 2,900 | 43.37 | 125,772 |
| 2014-09-15 | PTCT | Sale | 8,000 | 36.27 | 290,160 |
| 2013-06-25 | PTCT | Buy | 25,000 | 15.00 | 375,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rothera Mark (Chief Commercial Officer of Ptc Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.